Open AccessSafety evaluation of nonoxynol-9 gel in women at low risk of HIV infection
Author(s) -
Lut Van Damme,
Somchai Niruthisard,
R Atisook,
Kees Boer,
Leonard G. Dally,
Marie Laga,
Joep M. A. Lange,
Marc Karam,
Jos Perriëns
Publication year - 1998
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199804000-00013
Subject(s) - medicine , placebo , incidence (geometry) , colposcopy , microbicide , vagina , erythema , vaginal microbicide , randomized controlled trial , gynecology , surgery , population , microbicides for sexually transmitted diseases , human immunodeficiency virus (hiv) , immunology , cervical cancer , pathology , physics , alternative medicine , environmental health , cancer , optics , health services
To determine the safety of a vaginal microbicide, COL-1492, containing 52.5 mg nonoxynol-9, applied once daily for 14 days among healthy volunteers.